-
1
Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
Published 2009-02-01Subjects: Get full text
Article -
2
-
3
Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents
Published 2025-01-01Subjects: Get full text
Article -
4
Lack of Tissue Virological Response as a Predictor of Relapse in Chronic Hepatitis D after Completion Bulevirtide Therapy
Published 2024-12-01Subjects: Get full text
Article -
5
Telaprevir: options of application in separate patient groups
Published 2013-10-01Subjects: “…prolonged rapid virologic response…”
Get full text
Article -
6
-
7
Genotype 3 is linked to worse liver disease progression in hepatitis C patients even after SVR following DAA therapy
Published 2025-02-01Subjects: Get full text
Article -
8
Real-Life Experiences with Telaprevir in the Treatment of Chronic Genotype 1 Hepatitis C — The TEPS Study
Published 2019-01-01Subjects: Get full text
Article -
9